BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with COPD – a cross-sectional study

G. C. Funk, K. Kirchheiner, O. C. Burghuber, S. Hartl (Vienna, Austria)

Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Session: Organisation of care for individuals with chronic respiratory disease
Session type: E-Communication Session
Number: 3295
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. C. Funk, K. Kirchheiner, O. C. Burghuber, S. Hartl (Vienna, Austria). BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with COPD – a cross-sectional study. Eur Respir J 2009; 34: Suppl. 53, 3295

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comorbidities in COPD patients – their prevalence and correlation with BODE index
Source: Annual Congress 2009 - Quality of life and symptoms in COPD
Year: 2009

The effect of BODE index on quality of life and depressive symptoms in patients with COPD
Source: Annual Congress 2012 - The best posters on quality of life and coping styles in COPD
Year: 2012


An analysis for neuro-psychiatric symptoms in stable COPD patients and to assess for their correlation with patients‘ characteristics and BODE index
Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases
Year: 2012


Comparison of diagnostic value of patient health questionnaire 9 (PHQ-9) and Beck depression inventory (BDI) questionnaire for preliminary diagnosing of depression in COPD patients (pts)
Source: International Congress 2014 – COPD markers
Year: 2014


An acute bronchitis questionnaire (AECB-SS) discriminates between GOLD categories for COPD severity in patients screened for the MOSAIC study
Source: Eur Respir J 2004; 24: Suppl. 48, 239s
Year: 2004

BODCAT index: Could we use it instead of BODE or BODEx to classify COPD severity?
Source: International Congress 2014 – Clinical presentations
Year: 2014


The severity of anxiety in COPD patients (pts)
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016


The derivation of a new index of severity for COPD patients, the DOSE index: MRC dyspnea scale, airflow obstruction, smoking status and exacerbations
Source: Annual Congress 2007 - Predicting factors of patients undergoing rehabilitation
Year: 2007



The BODE index predicts mortality better than 2007 GOLD and GOLD ABCD
Source: International Congress 2014 – COPD exacerbations
Year: 2014


Change in BODE index, exacerbation duration and hospitalisation in a cohort of COPD patients
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008

Predictive validity of BODE index for anxious and depressive symptoms in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Outcomes and predictors of the sucess of pulmonary rehabilitation in chronic respiratory disease
Year: 2010

A clinical study on the consistency of a pre-screening questionnaire (11-Q) and the BODE index on subjects with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 62s
Year: 2005

Prevalence depression – Anxiety and impact on quality of life, asthma control and asthma severity in adult patients with asthma
Source: Annual Congress 2011 - Asthma: improving diagnosis and management for reaching better control
Year: 2011

The impact of depression and anxiety on never-smokers COPD patients
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016


The relationship between dyspnea and detection of depression in COPD patients (pts)
Source: International Congress 2015 – Different data in COPD
Year: 2015


The minimal important difference of the pulmonary functional status and dyspnea questionnaire – Modified version in patients with COPD
Source: Annual Congress 2011 - Rehabilitation, outcome measures and effects
Year: 2011

Change in clinical COPD questionnaire (CCQ) symptoms domain score and FEV1 predict treatment failure during hospitalisation due to COPD exacerbations
Source: Eur Respir J 2007; 30: Suppl. 51, 525s
Year: 2007

Multidimensional problem assessment of asthma and COPD in an older population: patient – physician concordance
Source: Annual Congress 2009 - Oxygen, end-of-life and care for chronic respiratory patients
Year: 2009


Who win? Spirometry versus symptoms for predicting the longitudinal outcomes in COPD patients – 10 years observation
Source: Annual Congress 2011 - Clinical parameters in airway diseases
Year: 2011

Lung function evaluation and patients’ satisfaction with Elpenhaler® device in Greek COPD patients with =1 comorbidity versus patients without comorbidities-AEOLOS study.
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020